[Treatment of new cases of pulmonary tuberculosis with a combination of isoprodian and ethambutol; clinical results (author's transl)].
D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D007539:Isonicotinic Acids / Q000627:therapeutic use*; D008297:Male; D011515:Prothionamide / Q000627:therapeutic use*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D004338:Drug Combinations; D007539:Isonicotinic Acids; D011515:Prothionamide; D004977:Ethambutol; D003622:Dapsone; D007538:Isoniazid
Klinische Erfahrungen über die Erstbehandlung der Lungentuberkulose mit Isoprodian und Ethambutol